Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Parents and Peer Recovery Supports to Increase Recovery Capital in Emerging Adults With Polysubstance Use: Feasibility, Acceptability, and Scaling up of Launch

NCT06414993 is registered in ClinicalTrials.gov with Chestnut Health Systems as lead sponsor.

NCT NCT06414993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Parents and Peer Recovery Supports to Increase Recovery Capital in Emerging Adults With Polysubstance Use: Feasibility, Acceptability, and Scaling up of Launch
Lead sponsor
Chestnut Health Systems
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 7, 2024
Completion date
September 1, 2026
Enrollment
48 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

polysubstance drug use (indiscriminate drug use)